Home › Funds › Morgan Stanley › RLAY
Morgan Stanley position in RLAY
RELAY THERAPEUTICS INC · Health Care
Latest position (Q2 2026)3.85M sh
Reported value held$72.05M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 446.79K | $14.09M | New |
| Q4 2021 | 523.49K | $16.08M | Add |
| Q1 2022 | 431.48K | $12.91M | Reduce |
| Q2 2022 | 626.12K | $10.49M | Add |
| Q3 2022 | 342.34K | $7.66M | Reduce |
| Q4 2022 | 2.37M | $35.40M | Add |
| Q1 2023 | 562.13K | $9.26M | Reduce |
| Q2 2023 | 777.47K | $9.76M | Add |
| Q3 2023 | 657.54K | $5.53M | Reduce |
| Q4 2023 | 728.70K | $8.02M | Add |
| Q1 2024 | 1.16M | $9.60M | Add |
| Q2 2024 | 1.24M | $8.10M | Add |
| Q3 2024 | 962.11K | $6.81M | Reduce |
| Q4 2024 | 1.30M | $5.36M | Add |
| Q1 2025 | 1.59M | $4.17M | Add |
| Q2 2025 | 1.42M | $4.92M | Reduce |
| Q3 2025 | 1.76M | $9.21M | Add |
| Q4 2025 | 2.02M | $17.08M | Add |
| Q1 2026 | 1.43M | $14.25M | Reduce |
| Q2 2026 | 3.85M | $72.05M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding RLAY
- Fidelity Management & Research (FMR) 20.11M sh · $376.26M · Q2 2026
- Casdin Capital 16.04M sh · $300.02M · Q2 2026
- BlackRock Inc 15.29M sh · $286.04M · Q2 2026
- Geode Capital Management 4.73M sh · $88.45M · Q2 2026
- Vanguard Group 9.69M sh · $81.99M · Q4 2025
- Goldman Sachs Group 3.41M sh · $63.78M · Q2 2026
- Bank of America Corp 2.70M sh · $50.43M · Q2 2026
- Arrowstreet Capital 2.24M sh · $41.89M · Q2 2026
- Northern Trust Corp 1.95M sh · $36.55M · Q2 2026
- Franklin Resources 1.86M sh · $34.74M · Q2 2026
- Charles Schwab Investment Management 1.50M sh · $28.08M · Q2 2026